| Literature DB >> 12570164 |
H J Møller1, H Aerts, H Grønbaek, N A Peterslund, P Hyltoft Petersen, N Hornung, L Rejnmark, E Jabbarpour, S K Moestrup.
Abstract
By immunoprecipitation we have identified a soluble plasma form of CD163 (sCD163), the IL-6 inducible macrophage-receptor for clearing haptoglobin-haemoglobin complexes. A sandwich ELISA for measuring sCD163 was established and used to determine the sCD163 levels in normal subjects and patients with inflammatory and myeloproliferative diseases. In normal subjects, the concentration of sCD163 was high (median 1.9 mg/l) with low intra-individual variation. Highly increased levels were seen in patients with sepsis, myeloid leukaemia and in patients with Gaucher disease characterized by accumulation of tissue macrophages. Although the physiological role of sCD163 remains unknown, our present data suggest that sCD163 might prove to be a valuable marker molecule in infectious and myeloproliferative diseases.Entities:
Mesh：
Substances：
Year: 2002 PMID： 12570164 DOI： 10.1080/003655102762377466
Source DB: PubMed Journal: Scand J Clin Lab Invest Suppl ISSN： 0085-591X